BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villas Boas GR, Boerngen de Lacerda R, Paes MM, Gubert P, Almeida WLDC, Rescia VC, de Carvalho PMG, de Carvalho AAV, Oesterreich SA. Molecular aspects of depression: A review from neurobiology to treatment. Eur J Pharmacol 2019;851:99-121. [PMID: 30776369 DOI: 10.1016/j.ejphar.2019.02.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL. Novel targets for parkinsonism-depression comorbidity. Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside. Elsevier; 2019. pp. 1-24. [DOI: 10.1016/bs.pmbts.2019.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
2 Cheiran Pereira G, Piton E, Moreira Dos Santos B, Ramanzini LG, Muniz Camargo LF, Menezes da Silva R, Bochi GV. Microglia and HPA axis in depression: An overview of participation and relationship. World J Biol Psychiatry 2021;:1-18. [PMID: 34100334 DOI: 10.1080/15622975.2021.1939154] [Reference Citation Analysis]
3 Harper AA, Rimmer K, Dyavanapalli J, McArthur JR, Adams DJ. Ketamine inhibits synaptic transmission and nicotinic acetylcholine receptor-mediated responses in rat intracardiac ganglia in situ. Neuropharmacology 2020;165:107932. [PMID: 31911104 DOI: 10.1016/j.neuropharm.2019.107932] [Reference Citation Analysis]
4 Moorkoth S, Prathyusha NS, Manandhar S, Xue Y, Sankhe R, Pai KSR, Kumar N. Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies. Pharmacol Rep 2021. [PMID: 34181212 DOI: 10.1007/s43440-021-00252-0] [Reference Citation Analysis]
5 Ahmad MH, Rizvi MA, Fatima M, Mondal AC. Pathophysiological implications of neuroinflammation mediated HPA axis dysregulation in the prognosis of cancer and depression. Mol Cell Endocrinol 2021;520:111093. [PMID: 33253761 DOI: 10.1016/j.mce.2020.111093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kibitov AO, Mazo GE. [Anhedonia in depression: neurobiological and genetic aspects]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:146-54. [PMID: 33834733 DOI: 10.17116/jnevro2021121031146] [Reference Citation Analysis]
7 Wu R, Wang H, Lv X, Shen X, Ye G. Rapid action of mechanism investigation of Yixin Ningshen tablet in treating depression by combinatorial use of systems biology and bioinformatics tools. J Ethnopharmacol 2020;257:112827. [PMID: 32276008 DOI: 10.1016/j.jep.2020.112827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mühle C, Wagner CJ, Färber K, Richter-Schmidinger T, Gulbins E, Lenz B, Kornhuber J. Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression. J Clin Med 2019;8:E846. [PMID: 31200571 DOI: 10.3390/jcm8060846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
9 Gong Q, Yan XJ, Lei F, Wang ML, He LL, Luo YY, Gao HW, Feng YL, Yang SL, Li J, Du LJ. Proteomic profiling of the neurons in mice with depressive-like behavior induced by corticosterone and the regulation of berberine: pivotal sites of oxidative phosphorylation. Mol Brain 2019;12:118. [PMID: 31888678 DOI: 10.1186/s13041-019-0518-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
10 Guan W, Xu DW, Ji CH, Wang CN, Liu Y, Tang WQ, Gu JH, Chen YM, Huang J, Liu JF, Jiang B. Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF. Pharmacol Res 2021;174:105932. [PMID: 34628001 DOI: 10.1016/j.phrs.2021.105932] [Reference Citation Analysis]
11 Zhou X, Xiao Q, Xie L, Yang F, Wang L, Tu J. Astrocyte, a Promising Target for Mood Disorder Interventions. Front Mol Neurosci 2019;12:136. [PMID: 31231189 DOI: 10.3389/fnmol.2019.00136] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
12 Li W, Ali T, Zheng C, He K, Liu Z, Shah FA, Li N, Yu ZJ, Li S. Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes. Mol Psychiatry 2021. [PMID: 34642455 DOI: 10.1038/s41380-021-01327-3] [Reference Citation Analysis]
13 Liu P, Yang P, Zhang L. Mode of Action of Shan-Zhu-Yu (Cornus officinalis Sieb. et Zucc.) in the Treatment of Depression Based on Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:8838888. [PMID: 33299459 DOI: 10.1155/2020/8838888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Getachew B, Tizabi Y. Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression. Behav Brain Res 2019;376:112220. [PMID: 31513828 DOI: 10.1016/j.bbr.2019.112220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Brivio E, Lopez JP, Chen A. Sex differences: Transcriptional signatures of stress exposure in male and female brains. Genes Brain Behav 2020;19:e12643. [PMID: 31989757 DOI: 10.1111/gbb.12643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
16 Villas-Boas GR, Lavorato SN, Paes MM, de Carvalho PMG, Rescia VC, Cunha MS, de Magalhães-Filho MF, Ponsoni LF, de Carvalho AAV, de Lacerda RB, da S Leite L, da S Tavares-Henriques M, Lopes LAF, Oliveira LGR, Silva-Filho SE, da Silveira APS, Cuman RKN, de S Silva-Comar FM, Comar JF, do A Brasileiro L, Dos Santos JN, de Freitas WR, Leão KV, da Silva JG, Klein RC, Klein MHF, da S Ramos BH, Fernandes CKC, de L Ribas DG, Oesterreich SA. Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence. Pharmaceuticals (Basel) 2021;14:148. [PMID: 33673205 DOI: 10.3390/ph14020148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Tunc-Ozcan E, Brooker SM, Bonds JA, Tsai YH, Rawat R, McGuire TL, Peng CY, Kessler JA. Hippocampal BMP signaling as a common pathway for antidepressant action. Cell Mol Life Sci 2021. [PMID: 34936033 DOI: 10.1007/s00018-021-04026-y] [Reference Citation Analysis]
18 Li C, Huang J, Cheng YC, Zhang YW. Traditional Chinese Medicine in Depression Treatment: From Molecules to Systems. Front Pharmacol 2020;11:586. [PMID: 32457610 DOI: 10.3389/fphar.2020.00586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 Zhao Y, Shang P, Wang M, Xie M, Liu J. Neuroprotective Effects of Fluoxetine Against Chronic Stress-Induced Neural Inflammation and Apoptosis: Involvement of the p38 Activity. Front Physiol 2020;11:351. [PMID: 32477152 DOI: 10.3389/fphys.2020.00351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Li X, Zhao J, Li Z, Zhang L, Huo Z. Applications of Acupuncture Therapy in Modulating the Plasticity of Neurodegenerative Disease and Depression: Do MicroRNA and Neurotrophin BDNF Shed Light on the Underlying Mechanism? Neural Plast 2020;2020:8850653. [PMID: 33029119 DOI: 10.1155/2020/8850653] [Reference Citation Analysis]
21 Sun Z, Jia L, Shi D, He Y, Ren Y, Yang J, Ma X. Deep brain stimulation improved depressive-like behaviors and hippocampal synapse deficits by activating the BDNF/mTOR signaling pathway. Behav Brain Res 2022;419:113709. [PMID: 34890598 DOI: 10.1016/j.bbr.2021.113709] [Reference Citation Analysis]
22 Joodaki M, Radahmadi M, Alaei H. Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression. Malays J Med Sci 2021;28:50-62. [PMID: 34512130 DOI: 10.21315/mjms2021.28.4.6] [Reference Citation Analysis]
23 Shalimova A, Babasieva V, Chubarev VN, Tarasov VV, Schiöth HB, Mwinyi J. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. Pharmacogenomics 2021;22:485-503. [PMID: 34018822 DOI: 10.2217/pgs-2020-0157] [Reference Citation Analysis]
24 Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 2020;40:1593-678. [PMID: 32115745 DOI: 10.1002/med.21666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
25 Rothenberg DO, Zhang L. Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption. Nutrients 2019;11:E1361. [PMID: 31212946 DOI: 10.3390/nu11061361] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
26 Mncube K, Möller M, Harvey BH. Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression. Front Psychiatry 2021;12:688150. [PMID: 34867504 DOI: 10.3389/fpsyt.2021.688150] [Reference Citation Analysis]
27 Kowalska M, Fijałkowski Ł, Nowaczyk A. Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters. Int J Mol Sci 2021;22:6293. [PMID: 34208199 DOI: 10.3390/ijms22126293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chang Z, He LJ, Tian DF, Gao Q, Ling JF, Wang YC, Han ZY, Guo RJ. Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study. Evid Based Complement Alternat Med 2021;2021:5516525. [PMID: 34257681 DOI: 10.1155/2021/5516525] [Reference Citation Analysis]